Please login to the form below

Not currently logged in
Email:
Password:

EFPIA

This page shows the latest EFPIA news and features for those working in and with pharma, biotech and healthcare.

Trust – years to build, seconds to break and forever to repair

Trust – years to build, seconds to break and forever to repair

KISS (keep it simple stupid). Many companies and associations, like EFPIA and the ABPI, have been working to capitalise on the public’s thirst for knowledge that now exists, producing simple

Latest news

  • Who's calling the shots in European healthcare? Who's calling the shots in European healthcare?

    EFPIA: We’re looking forward to working with MEPs, the Commission and Council as they look to the next mandate. ... EFPIA recently set out its manifesto of nine concrete proposals:. Drive the evolution towards outcomes-focused healthcare systems.

  • Von der Leyen elected new European Commission president Von der Leyen elected new European Commission president

    Europe’s pharma industry association EFPIA will be hoping for a strong Commission so that reforms – including pro-industry and pro-innovation policies – can be achieved over the next five years, ... EFPIA had fought against the changes, arguing

  • Ursula von der Leyen nominated for EU President role Ursula von der Leyen nominated for EU President role

    Europe’s pharma association EFPIA has been careful not to comment on the formation of the new EU leadership, but is continuing to promote its agenda for the next five years. ... EFPIA yesterday called for a ‘refreshed approach’ to the plans,

  • European elections: Eurosceptics and Greens rise, but big parties hold on European elections: Eurosceptics and Greens rise, but big parties hold on

    Pharma’s perspective. While Europe’s pharma lobby group EFPIA has been as careful as ever to stay out of endorsing candidates, its leaders did urge Europeans to take part in ... EFPIA's Nathalie Moll. When the elections kicked off last week,

  • As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority

    The programme is particularly vital in health research, and six European health industry associations, including the pharma sector’s EFPIA have thrown their weight behind the new framework, which creates ... Welcoming the agreement between EU’s

More from news
Approximately 35 fully matching, plus 154 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 33 partially matching documents found.

Latest appointments

  • EFPIA appoints new director general EFPIA appoints new director general

    Joe Jiminez, president of EFPIA, said: “Nathalie has an excellent track record of leadership and engagement across the life science sector. ... We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges

  • IFPMA appoints director general IFPMA appoints director general

    Thomas Cueni brings expertise from Interpharma and EFPIA. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has selected Thomas Cueni as its new director general. ... Cueni also brings industry expertise from the

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    He also brings branding and sales leadership experience from Novar tis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    Currently an independent consultant based in Basel, Switzerland, Cornut brings over 25 years of pharmaceutical management experience to the role, including five years as chairman of EFPIA's executive committee. ... work. “I am very pleased that Eric

  • EFPIA director general Richard Bergström resigns EFPIA director general Richard Bergström resigns

    Richard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post. ... Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe

More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • EU Pharmaceutical Strategy Roadmap EU Pharmaceutical Strategy Roadmap

    It seems that in the Roadmap, the Commission has responded to calls from industry, including the European Federation of Pharmaceutical Industries and Federations (EFPIA) and the European Confederation of Pharmaceutical Entrepreneurs

  • The changing face of medical communications over the past 15 years

    Similarly, the launch of Disclosure UK’s searchable database, which went live in June 2016, is a helpful development for the UK (and Europe-wide through EFPIA), although details don’t

  • How Transparent Is Transparency?

    So, what have we learnt? Is the  EFPIA  mission – to provide a greater understanding of the merits and ethics of the interactions between pharmaceutical companies and healthcare professionals (HCPs) – bearing any ... The EFPIA vision of enhanced

  • Compliance Hub Ltd

    Specialists in ABPI, ABHI and EFPIA codes of practice - provides training, audit and consultancy services.

  • Cameron Medical Communications Ltd

    We specialise in: Marketing Codes of Practice, ABPI, EFPIA, IFPMA, Medical Information Systems and Services and Copyright.

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics